01-Nov-2026 18:19:23
SAIPARENTGeneral news
SAIPARENT Q2 : CONS NET PROFIT UP 45.8% AT ₹10.5 CR (YOY), UP 32.7% (QOQ). GOOD (ON 1ST LOOK)
Revenue at ₹196.1 Cr v ₹54.9 Cr (YOY), up 9.0% (QOQ); H1 revenue ₹376.0 Cr is ~50% of FY27 target ₹750 Cr. Ebitda at ₹41.4 Cr v ₹12.8 Cr (YOY), up 67.4% (QOQ); Ebitda margin 21.1% v 23.3% (YOY), 13.7% (QOQ). Gross margin 47.5% v 36.7% (YOY), 40.9% (QOQ); H1 Ebitda margin 17.6% ahead of ~17% FY27 guidance. Caution: YOY comparison is not like-for-like as Noumed was consolidated only from November 12, 2025.
Sai Parenterals Ltd
Open attachment